drugset / Trial / NCT04164121
A Clinical Study Trial of Phenlarmide in China
RandomizedParallel-groupQuadruple-blindOther
Summary
1. To evaluate the tolerance and safety of FLA tablets in healthy volunteers. 2. To evaluate the pharmacokinetics of FLA tablets in healthy volunteers. 3. Provide basis for dosage setting for follow-up clinical research.
Timeline
- Start
- 2019-12-17
- Primary completion
- 2020-12-02
- Completion
- 2020-12-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Phenlarmide | Unknown | 150 mg | Oral |
| Subject | Phenlarmide | Unknown | 600 mg | Oral |
| Subject | Phenlarmide | Unknown | 900 mg | Oral |